Ucardia Acquires Phas3 to Launch Ucardia-at-Home Remote Cardiac Monitoring

CardioOne Acquires CardioDiagnostics

April 24, 2025

Healthcare Services

CardioOne, a national growth and operational partner for independent cardiology practices, has acquired CardioDiagnostics, a provider of advanced ECG and remote patient monitoring (RPM) technologies. The deal integrates CardioDiagnostics’ cloud-based monitoring, analytics and RPM capabilities into CardioOne’s practice management platform to expand virtual care and enhance cardiology practice services.

Kardigan Acquires Prolaio

March 27, 2025

Data & Analytics

Kardigan has acquired Prolaio, a Chicago-based clinical intelligence company, to integrate Prolaio's cardiovascular data, FDA-cleared monitoring software, and analytics into Kardigan's cardiac R&D platform. The acquisition gives Kardigan access to a large curated CV dataset and analytics capabilities intended to accelerate and optimize its cardiovascular drug development programs.

Cirtec Medical Acquires Cardea Catheter Innovations

July 26, 2021

Medical Devices

Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.

ARCHIMED Acquires Majority Stake in Cardioline

November 17, 2021

Medical Devices

Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.

Pharos Capital Makes Majority Investment in RhythMedix

January 4, 2024

Medical Devices

Pharos Capital Group has acquired a majority stake in RhythMedix, a Mount Laurel, New Jersey-based maker of wearable cardiac monitoring devices and related services. RhythMedix's management is reinvesting and will remain in place; Pharos plans to support growth through increased R&D, market share expansion, and add-on acquisitions to broaden remote patient monitoring capabilities.

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.